Fast-tracking advanced therapies without compromising regulatory success
Early planning for potency CQAs, comparability and evolving global regulations…
Early planning for potency CQAs, comparability and evolving global regulations can set advanced therapies on the fastest path to approval. Dr Christian Schneider shares how to prepare from the start to accelerate development without compromising the evidence regulators expect.